Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Bundy

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Arthritis Care & Research|August 20, 2020
Patient-Reported Impact of Axial Spondyloarthritis on Working Life: Results From the European Map of Axial Spondyloarthritis SurveyMarco Garrido-Cumbrera, Christine Bundy, Victoria Navarro-Compán, et al.
Rheumatology (Oxford, England)|September 25, 2024
Diagnostic delay in patients from the International Map of Axial Spondyloarthritis: geographic, sociodemographic and disease-related factorsDenis Poddubnyy, Marco Garrido-Cumbrera, Fernando Sommerfleck, et al.
Rheumatology (Oxford, England)|April 28, 2021
Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritisMarco Garrido-Cumbrera, Victoria Navarro-Compán, Christine Bundy, et al.
International Journal of Rheumatic Diseases|December 10, 2024
Females With Axial Spondyloarthritis Have Longer Diagnostic Delay and Higher Burden of the Disease. Results From the International Map of Axial Spondyloarthritis (IMAS)Victoria Navarro-Compán, Marco Garrido-Cumbrera, Denis Poddubnyy, et al.
Rheumatology and Therapy|June 7, 2024
Regional Differences in Diagnosis Journey and Healthcare Utilization: Results from the International Map of Axial Spondyloarthritis (IMAS)Marco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, et al.
Joint Bone Spine|March 27, 2021
A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to actionJordi Gratacós, Frank Behrens, Laura C Coates, et al.
Clinical Rheumatology|January 19, 2021
Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS)Marco Garrido-Cumbrera, Denis Poddubnyy, Laure Gossec, et al.
RMD Open|June 8, 2024
International Map of Axial Spondyloarthritis (IMAS): results from the perspective of 5557 patients from 27 countries around the globeMarco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, et al.
Rheumatology (Oxford, England)|December 21, 2023
Regional differences in clinical phenotype of axial spondyloarthritis: results from the International Map of Axial Spondyloarthritis (IMAS)Denis Poddubnyy, Fernando Sommerfleck, Victoria Navarro-Compán, et al.
Dermatology and Therapy|November 23, 2021
Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE StudyToni Maria Klein, Christine Blome, C Elise Kleyn, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Arthritis Care & Research|August 20, 2020
Patient-Reported Impact of Axial Spondyloarthritis on Working Life: Results From the European Map of Axial Spondyloarthritis SurveyMarco Garrido-Cumbrera, Christine Bundy, Victoria Navarro-Compán, et al.
Rheumatology (Oxford, England)|September 25, 2024
Diagnostic delay in patients from the International Map of Axial Spondyloarthritis: geographic, sociodemographic and disease-related factorsDenis Poddubnyy, Marco Garrido-Cumbrera, Fernando Sommerfleck, et al.
Rheumatology (Oxford, England)|April 28, 2021
Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritisMarco Garrido-Cumbrera, Victoria Navarro-Compán, Christine Bundy, et al.
International Journal of Rheumatic Diseases|December 10, 2024
Females With Axial Spondyloarthritis Have Longer Diagnostic Delay and Higher Burden of the Disease. Results From the International Map of Axial Spondyloarthritis (IMAS)Victoria Navarro-Compán, Marco Garrido-Cumbrera, Denis Poddubnyy, et al.
Rheumatology and Therapy|June 7, 2024
Regional Differences in Diagnosis Journey and Healthcare Utilization: Results from the International Map of Axial Spondyloarthritis (IMAS)Marco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, et al.
Joint Bone Spine|March 27, 2021
A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to actionJordi Gratacós, Frank Behrens, Laura C Coates, et al.
Clinical Rheumatology|January 19, 2021
Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS)Marco Garrido-Cumbrera, Denis Poddubnyy, Laure Gossec, et al.
RMD Open|June 8, 2024
International Map of Axial Spondyloarthritis (IMAS): results from the perspective of 5557 patients from 27 countries around the globeMarco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, et al.
Rheumatology (Oxford, England)|December 21, 2023
Regional differences in clinical phenotype of axial spondyloarthritis: results from the International Map of Axial Spondyloarthritis (IMAS)Denis Poddubnyy, Fernando Sommerfleck, Victoria Navarro-Compán, et al.
Dermatology and Therapy|November 23, 2021
Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE StudyToni Maria Klein, Christine Blome, C Elise Kleyn, et al.
Pageof 6